|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dichloroethyl ether | CAS 111-44-4 | ||
| (ClCH2CH2)2O | RTECS KN0875000 | ||
|
Synonyms & Trade Names bis(2-Chloroethyl)ether; 2,2'-Dichlorodiethyl ether, 2,2'-Dichloroethyl ether |
DOT ID & Guide 1916 152 |
||
|
Exposure Limits |
NIOSH REL: Ca TWA 5 ppm (30 mg/m3) ST 10 ppm (60 mg/m3) [skin] See Appendix A | ||
| OSHA PEL�: TWA 15 ppm (90 mg/m3) [skin] | |||
| IDLH Ca [100 ppm] | Conversion 1 ppm = 5.85 mg/m3 | ||
|
Physical Description Colorless liquid with a chlorinated solvent-like odor. |
|||
|
MW: 143.0 |
BP: 352°F |
FRZ: -58°F |
Sol: 1% |
|
VP: 0.7 mmHg |
IP: ? |
|
Sp.Gr: 1.22 |
|
Fl.P: 131°F |
UEL: ? |
LEL: 2.7% |
|
| Class II Combustible Liquid: Fl.P. at or above 100�F and below 140�F. | |||
|
Incompatibilities & Reactivities Strong oxidizers [Note: Decomposes in presence of moisture to form hydrochloric acid.] |
|||
|
Measurement Methods NIOSH 1004; OSHA 7 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation nose, throat, respiratory system; lacrimation (discharge of tears); cough; nausea, vomiting; in animals: pulmonary edema; liver damage; [potential occupational carcinogen] | |
|
Target Organs
Eyes, respiratory system, liver Cancer Site [in animals: liver tumors] |
|
| See also: INTRODUCTION |